Navigation Links
InspireMD Appoints Dr. James Barry to Its Board of Directors
Date:1/31/2012

device and biological systems for applications with implantable and catheter-based delivery systems. Under Dr. Barry's leadership, the company developed the TAXUS® paclitaxel-eluting coronary stent that became one of the most successful medical devices launched, achieving first year sales in excess of $3 billion.

Prior to Boston Scientific, Dr. Barry worked at Howmedica (Division of Pfizer) and Kontron Instruments.  He has authored multiple articles in peer reviewed publications, including several clinical journals in the cardiovascular field. He currently serves on a number of advisory boards including the College of Biomedical Engineering at Yale University, the College of Sciences at University of Massachusetts-Lowell, and the Massachusetts Life Science Center. Dr. Barry received his Ph.D. in Biochemistry from the University of Massachusetts-Lowell and holds a B.A. degree in Chemistry from Saint Anselm College.

About InspireMD, Inc.

InspireMD is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard™. InspireMD intends to pursue applications of this technology in coronary, carotid and peripheral artery procedures. InspireMD's common stock is listed on the OTC BB under the ticker symbol "NSPR".

Forward-looking Statements:

This press release contains "forward-looking statements." Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forw
'/>"/>

SOURCE InspireMD, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. InspireMD Elects Sol J. Barer, Ph.D. Chairman of the Board of Directors
2. InspireMD Presents 2 Years Clinical Outcome of MGuard Multicenter Experience in STEMI Patients. The New Superb Clinical Results Were celebrated at InspireMDs TCT Satellite Symposium in Washington DC., Today.
3. InspireMD Announces the Enrollment of the 1st Patient in the MGuard(TM) Israeli Registry. InspireMD Will Also Sponsor a Satellite Program Breakfast Meeting at the TCT Conference on September 24th 2009 in the Moscone Exhibition Center in San Francisco
4. InspireMD Announce the Completion of Enrollment for the MAGICAL Trial (MGuard(TM) in Acute Myocardial Infarction) at EuroPCR 09. Results Will be Presented May 21st by Dr. Dariusz Dudek at the InspireMD Cocktail Reception Debate Chaired by Prof. Martin Le
5. MGuard(TM), InspireMDs Novel Coronary Stent System, was Celebrated by World Leading Interventional Cardiologists at the Transcatheter Cardiovascular Therapeutics (TCT) in Washington DC, USA, October 12-17 2008
6. InspireMD Announces Enrollment of First Patients in the MGuard(TM) Acute Myocardial Infarction Clinical Trial Data Will be Used to Confirm Initial Positive Results
7. Veracyte Appoints Mark Spring as Chief Financial Officer
8. MAP Pharmaceuticals Appoints W. James OShea to Board of Directors
9. PAREXEL Appoints Former Senior FDA Official David Elder to Global Team of Strategic Compliance Experts
10. PuraMed BioScience, Inc. Appoints Sue A. Baacke, CPA, as CFO
11. Oxford BioTherapeutics Appoints C. Glenn Begley as a Senior Clinical Advisor and Non-executive Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Los Angeles, CA (PRWEB) September 30, 2014 ... Separation (EWS), the high-speed, chemical-free process to clean up ... letter to shareholders, CEO Riggs Eckelberry reported on the ... West Texas, at a site provided by partner ... ramped up to 1000 barrels per day (bpd) and ...
(Date:9/30/2014)... 30, 2014 iLab Solutions announced the ... study which focuses on core facility operations, growth ... managers face today. , In its 4th year running, ... note is the year-over-year decrease in the percentage of ... to be feeling the constraints of this trend. When ...
(Date:9/30/2014)... MA (PRWEB) September 30, 2014 ... (UC) and collaboration company is dedicated to supporting ... connectivity needs. Julie Power, a carrier ... to ensure collaboration solutions stays connected and productive ... to the increased movement of businesses to cloud ...
(Date:9/30/2014)... Jersey (PRWEB) September 30, 2014 ... has been chosen by the Parenteral Drug Association ... 18 and 19, 2014) on container closure integrity testing. ... closure integrity test methods and philosophies detailed in the ... Integrity Evaluation. The course will span container ...
Breaking Biology Technology:OriginOil, Inc. Report to Shareholders: Blue Gold in West Texas 2iLab Solutions Announces the Results of the 2014 Core Facility Benchmarking Study 2iLab Solutions Announces the Results of the 2014 Core Facility Benchmarking Study 3SoundConnect Expands Carrier Services Division 2Whitehouse Laboratories to Partner with PDA for Educational Course on Container Closure Integrity Testing 2Whitehouse Laboratories to Partner with PDA for Educational Course on Container Closure Integrity Testing 3Whitehouse Laboratories to Partner with PDA for Educational Course on Container Closure Integrity Testing 4
... Oct. 26, 2011 The following is a letter ... Ltd. (OTCBB: HADSY), a publicly traded portfolio of biotech ... Hadassah University Hospital. Dear Fellow Investors, ... establishment by the Hadassah University Hospital and its IPO ...
... this smorgasbord of recent salmonella outbreaks in the United ... 2011 alone, and the list goes on, according to ... perhaps not for long, thanks to a promising new ... bacteria before contaminated food or animals reach the marketplace. ...
... and IPSWICH, Mass., Oct. 25, 2011 SwitchGear ... services for studying regulatory elements in the human genome, ... Inc. (NEB) to create a new dual reporter assay ... Luciferase Assay System and NEB,s BioLux® Cypridina ...
Cached Biology Technology:Summary Letter to Hadasit Bio-Holdings Ltd. Shareholders 2Summary Letter to Hadasit Bio-Holdings Ltd. Shareholders 3Summary Letter to Hadasit Bio-Holdings Ltd. Shareholders 4Summary Letter to Hadasit Bio-Holdings Ltd. Shareholders 5Summary Letter to Hadasit Bio-Holdings Ltd. Shareholders 6SwitchGear Genomics and New England Biolabs Develop New Multiplex Reporter Assay System 2
(Date:9/30/2014)... New England Journal of Medicine reports positive ... drug crizotinib against the subset of lung cancer marked ... study of 50 patients with advanced non-small cell lung ... rate was 72 percent, with 3 complete responses and ... it takes for the disease to resume its growth ...
(Date:9/30/2014)... Munich report that a new class of chemical ... drugs. They have also pinpointed the relevant target ... agents. , Researchers led by LMU,s Professor ... Technische Universitt Mnchen have identified a class of ... the fight against malignant tumors. The compound is ...
(Date:9/30/2014)... perilous threats in today,s ocean. From overfishing and ... coral ecosystems are disappearing at unprecedented rates around ... corals surrounding the island of Moorea in French ... environment: coral guard-crabs. New research from the National ... Seabird McKeon and the museum,s predoctoral fellow Jenna ...
Breaking Biology News(10 mins):NEJM: Crizotinib effective in Phase 1 trial against ROS1 lung cancer 2Cancer therapy: Driving cancer cells to suicide 2Smithsonian scientists discover coral's best defender against an army of sea stars 2
... Genetic factors explain some of the variation in a ... such as preferences toward environmental policy and financial ... variants are likely to be very small, according to ... Daniel Benjamin. The research team arrived at the ...
... by the European Commission,s in-house science service, the Joint Research ... managers on how to assess the environmental impacts of products ... resource-efficient Europe and aims to help design more sustainable products, ... and limited resources. , The increasing world population and ...
... created an ultrasensitive biosensor that could open up ... "personalized medicine" tailored to the specific biochemistry of ... several hundred times more sensitive than other biosensors, ... of sensors, said Muhammad A. Alam, a Purdue ...
Cached Biology News:New evidence that many genes of small effect influence economic decisions and political attitudes 2A practical guide to green products and services 2Ultrasensitive biosensor promising for medical diagnostics 2
... Mouse polyclonal antibody raised against ... Immunogen: PPP4C ... a.a) partial recombinant protein with ... Accession Number: NM_002720 ...
... Eppendorf Thermomixer R offers maximum application ... shaking, heating, and cooling. Its active ... application and temperature control ranges. Five ... 24 micro test tubes, are available ...
Mouse monoclonal antibody raised against a partial recombinant PDE2A. NCBI Entrez Gene ID = PDE2A...
... II can be used to test the ... and sera that are commonly used as ... contains spots for 19 different protein preparations ... antibody crossreactivity and species specificity, QC of ...
Biology Products: